Han-Ning Li (Hanning Li)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Cell Cycle Arrest

Estrogen Receptor

Top Venues

The Journal of clinical endocrinology and metabolism

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Han-Ning Li, Hui-Min Zhang, Xing-Rui Li, Jun Wang, Tao Xu, Shu-Yu Li, Meng-Lu Dong, Ge Wang, Xiao-Qing Cui, Xue Yang, Yong-Lin Wu, Xing Hua Liao, Ya-Ying Du
MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44. Endocrinology 163 (4) (2022)
Han-Ning Li, Xiang Zhou, Ge Wang, Dongyu Hua, Shuyu Li, Tao Xu, Menglu Dong, Xiaoqing Cui, Xue Yang, Yonglin Wu, Miaomiao Cai, Xinghua Liao, Tongcun Zhang, Zhifang Yang, Ya-Ying Du, Xingrui Li
CAR-T cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer. The Journal of clinical endocrinology and metabolism (2021)
Han-Ning Li, Xing-Rui Li, Zheng-Tao Lv, Miao-Miao Cai, Ge Wang, Zhi-Fang Yang
Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status. Cancer medicine 9 (24) (2020)